期刊文献+

乌头汤治疗肾虚督寒型强直性脊柱炎30例临床观察 被引量:7

Clinical Observation on 30 Cases of Ankylosing Spondylitis of Kidney Deficiency and Du Meridian Cold Type Treated with Wutou Tang(乌头汤)
下载PDF
导出
摘要 目的:观察乌头汤治疗肾虚督寒型强直性脊柱炎的临床疗效。方法:将60例活动期肾虚督寒型强直性脊柱炎患者随机分为治疗组和对照组,每组30例。治疗组口服乌头汤治疗,对照组口服美洛昔康片治疗。2组均以4周为1个疗程。观察2组ASAS20疗效、ASAS40疗效、中医证候疗效,以及治疗前后脊柱痛视觉模拟评分法(VAS)评分、患者自我评价VAS评分、Bath强直性脊柱炎功能指数(BASFI)、Bath强直性脊柱炎活动指数(BASDAI)、中医证候积分等指标,并评估安全性。结果:治疗组ASAS40达标率为33.33%,明显优于对照组的6.67%,2组比较,差异有统计学意义(P<0.05)。2组中医疗效总有效率均为83.33%,差异无统计学意义(P>0.05)。治疗后,2组脊柱痛VAS评分、患者自我评价VAS评分、BASFI、BASDAI较治疗前均有一定改善,差异有统计学意义(P<0.05);2组间各指标比较,差异无统计学意义(P>0.05)。结论:乌头汤对肾虚督寒型强直性脊柱炎的临床疗效较好,且安全性高。 Objective:To observe the clinical effect of Wutou Tang(乌头汤)on ankylosing spondylitis of kidney deficiency and Du Meridian cold type.Methods:Sixty cases of active ankylosing spondylitis of kidney deficiency and Du Meridian cold type were randomly divided into a treatment group and a control group,30 cases in each group.The treatment group was treated with Wutou Tang,while the control group was treated with meloxicam tablets.Both groups were treated for 4 weeks as a course.The efficacy of ASAS20 and ASAS40,TCM syndrome efficacy,and evaluate the security,visual analogue scale(VAS)score of spinal pain,VAS score of patients'self-evaluation,Bath Ankylosing Spondylitis Functional Index(BASFI),Bath Ankylosing Spondylitis Activity Index(BASDAI),TCM syndrome score and other indicators were observed before and after treatment in the two groups.Results:The compliance rate of ASAS40 in the treatment group was 33.33%,which was significantly better than 6.67%in the control group,and the difference was statistically significant(P<0.05).The total effective rate of the two groups was 83.33%,and the difference was not statistically significant(P>0.05).After treatment,the VAS,VAS score of spinal pain,VAS score of patients'self-evaluation,BASDAI and BASFI of the two groups were improved compared with those before treatment,and the difference was statistically significant(P<0.05),but there was no significant difference between the two groups(P>0.05).Conclusion:Wutou Tang is effective and safe in treating ankylosing spondylitis of kidney deficiency and Du Meridian cold type.
作者 程青青 李炜 程鹏 刘兆宜 汪荣盛 沈逸 秦盈盈 唐小蓉 沈杰 朱琦 何东仪 姜婷 CHENG Qing-qing;LI Wei;CHENG Peng;LIU Zhao-yi;WANG Rong-sheng;SHEN Yi;QIN Ying-ying;TANGXiao-rong;SHEN Jie;ZHU Qi;HE Dong-yi;JIANG Ting
出处 《风湿病与关节炎》 2021年第2期5-7,27,共4页 Rheumatism and Arthritis
基金 上海市卫计委基金项目(201640121) 上海市中西医临床协作试点项目[ZY(2018-2020)-FWTX-1010] 上海市中医专科联盟建设项目[ZY(2018-2020)-FWTX-4017]。
关键词 脊柱炎 强直性 肾虚督寒证 乌头汤 美洛昔康 临床疗效 spondylitis,ankylosing kidney deficiency and Du Meridian syndrome Wutou Tang(乌头汤) meloxicam clinical efficacy
  • 相关文献

参考文献10

二级参考文献90

  • 1朱小泉,曾庆馀,孙亮,王钢,唐雷,侯志铎,王庆文,林玲,王沥,杨泽.强直性脊柱炎的新易感基因识别研究[J].遗传,2005,27(1):1-6. 被引量:15
  • 2Breweton DA,Hart FD,Nicholls A,et al.Ankylosingspondylitis and HLA-B27[J].Lancet,1973(1):904-907.
  • 3Schlosstein L,Terasaki PI,Bluestone R,et al.High association of an HLA antigen,W27 with ankylosing spondylitis[J].New Eng J Med,1973,288(14):704-706.
  • 4Brown MA,Pile KD,Kennedy LG,et al.A genomewide screen for susceptibility loci in ankylosing spondylitis[J].Arthritis Rheum,1998,41(4):588-595.
  • 5Rostom S,Dougados M,Gossec L,et al.New toolsfordiagnosing spondyloarthropathy[J].Joint BoneSpine,2010,77(2):108-114.
  • 6Evans DM,Spencer CC,Pointon JJ,et al.Interactionbetween ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanismfor HLA-B27 in disease susceptibility[J].Nat Genet,2011,43(8):761-767.
  • 7Mou YK,Zhang PP,Li QX,et al.Changes of serumlevels of MMP-3,s RANKL,and OPG in juvenile-onset ankylosing spondylitis patients carrying differentHLA-B27 subtypes[J].Clinical rheumatology,2015,34(6):1085-1089.
  • 8Frauendorf E,Von Goessel H,May E,et al.HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similarto bacteria-derived peptides[J].Clin Exp Immunol,2003,134(2):351-359.
  • 9De Lay ML,Turner MJ,Klenk EI,et al.HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats[J].Arthritis Rheum,2009,60(9):2633-2643.
  • 10Breban M,Hacqard-Bouder C,Falgarone G.Animalmodels of HLA-B27-associated diseases[J].Curr MolMed,2004,4(1):31-40.

共引文献911

同被引文献142

引证文献7

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部